This week's most significant market movement centers on the COVID-19 lab leak probability. The likelihood of a confirmed US lab leak in 2024 has risen from 28% to 35%, reflecting heightened investigative momentum from the House Select Subcommittee's recent report.

In a closely watched geopolitical market, the probability of Chinese government acknowledgment has marginally declined from 15% to 12%, indicating skepticism about potential diplomatic admissions.

A third notable market shows increased speculation around potential NIH oversight reforms, with probabilities jumping from 22% to 38% following detailed findings about research funding procedures.

These shifts underscore growing market confidence in emerging COVID-19 origin investigations, with investors and analysts closely tracking potential official confirmations and institutional accountability.

The markets continue to price in evolving geopolitical and scientific revelations around this critical global health question.